Continuous renal replacement therapy with oXiris® in patients with hematologically malignant septic shock: A retrospective study

Table 2 Continuous renal replacement therapy treatment condition, n (%)

0.530 (χ2)	oXiris® group (n = 26)	CRRT group (n = 19)	χ2	P value
CRRT			0.530	0.467
CVVH	18 (69.2)	15 (78.9)
CVVHDF	8 (30.8)	4 (21.1)
citrate	96.15 (25)	100	0.747f	1
No anticoagulation	3.65 (1)	0	0.747f	1
Time between ICU admission and initiation of blood	5 (3, 21.25)	15 (3, 22)	-0.761z	0.447
Total CRRT hours	58 (48, 88.5)	86 (39, 122)	-0.726z	0.468
Sessions	2 (1, 2)	2 (1, 3)	-1.141z	0.254

^fFisher’s exact test.

^zMann–Whitney U test.

CRRT: continuous renal replacement therapy; CVVH: Continuous venovenous hemodiafiltration; CVVHDF: Continuous venovenous hemodiafiltration; ICU: Intensive care unit.